These SCFAs also modulate metabolic parameters by influencing glucose and lipid metabolism through G-protein-coupled receptor activation and histone deacetylase inhibition, thereby inducing anti-obesity and insulin-sensitizing effects [46]. Here, INS is linked to obesity due to melanocortin 4 receptor deficiency.